The current status and future trends of BTK inhibitor for diffuse large B cell lymphoma.

Pharmacol Res

Department of Hematology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu Province 223300, PR China; Key Laboratory of Autoimmune Diseases of Huaian City, Huaian, Jiangsu Province 223300, PR China. Electronic address:

Published: September 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2024.107337DOI Listing

Publication Analysis

Top Keywords

current status
4
status future
4
future trends
4
trends btk
4
btk inhibitor
4
inhibitor diffuse
4
diffuse large
4
large cell
4
cell lymphoma
4
current
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!